Milestone Pharmaceuticals Inc.
corporate_fare Company Profile
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for MIST at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Milestone Pharmaceuticals Closes $75M Royalty Sale, Securing Substantial Capital
- Milestone Pharma's Etripamil Nasal Spray MAA Accepted by EMA for PSVT
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$63.06M
Diluted EPS
-$0.75
Op. Cash Flow
-$49.04M
Free Cash Flow
-$49.34M
Operating Income
-$62.14M
Cash & Equivalents
$73.05M
Total Debt
$57.19M
Debt / Equity
1.37×
Shares Outstanding
106.24M sh
Source: 10-K · filed 2026-03-20 · accession 0001104659-26-032415
show_chartPrice Chart
Loading chart...